Haeberlein spoke about a number of topics in the Alzheimer space, including the progress that has been made and her excitement for the future.
Samantha Budd Haeberlien, PhD
Advertisement
Articles by Samantha Budd Haeberlien, PhD
Advertisement
Latest Updated Articles
Samantha Budd Haeberlien, PhD: Progress in Alzheimer Drug DevelopmentPublished: August 10th 2018 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Reverses Course on AMT-130, Citing Insufficient External Data for Submission
2
Early Phase 3 Data Highlight Convenience and Feasibility of Self-Administered Alzheimer Agent Remternetug
3
Exploring Complement Inhibition and Claseprubart in CIDP
4
Exploring New Therapeutic Targets for Neurodegenerative Diseases: Robert G. Kalb, MD
5
